Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncoinvent ASA | 5.08m | -101.06m | 177.86m | 7.00 | -- | 0.3849 | -- | 35.03 | -176.33 | -176.33 | 8.86 | 109.85 | 0.0354 | -- | 0.4134 | 360,333.30 | -70.49 | -68.76 | -88.81 | -82.93 | -- | -- | -1,990.44 | -40,397.77 | -- | -- | 0.00 | -- | 139.55 | -37.51 | 26.85 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | 11.23m | -58.70m | 202.68m | 4.00 | -- | 44.60 | -- | 18.04 | -0.4069 | -0.3093 | 0.0699 | 0.0185 | 0.201 | -- | 5.34 | 2,808,250.00 | -105.02 | -48.20 | -649.38 | -74.06 | -- | -- | -522.58 | -1,522.52 | -- | -2.47 | 0.1195 | -- | -73.41 | -11.85 | -33.44 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -16.44m | 203.76m | 2.00 | -- | 4.44 | -- | -- | -0.2729 | -0.2729 | 0.00 | 0.671 | 0.00 | -- | -- | 0.00 | -43.00 | -67.58 | -46.15 | -73.43 | -- | -- | -- | -- | -- | -- | 0.0619 | -- | -- | -- | 53.32 | -- | -- | -- |
| Xbrane Biopharma AB | 209.08m | -72.86m | 206.47m | 26.00 | -- | 0.3517 | -- | 0.9875 | -5.16 | 8.99 | 14.57 | 28.49 | 0.2713 | 0.2899 | 5.00 | 3,216,539.00 | -9.46 | -37.48 | -15.30 | -65.13 | 71.25 | -- | -34.85 | -233.69 | 1.71 | -1.49 | 0.00 | -- | -16.76 | -- | 17.70 | -- | 113.17 | -- |
| Dextech Medical AB | 0.00 | -4.96m | 210.74m | 1.00 | -- | 8.81 | -- | -- | -0.2684 | -0.2684 | 0.00 | 1.29 | 0.00 | -- | -- | 0.00 | -18.58 | -19.36 | -18.94 | -19.80 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.96 | -- | 40.14 | -- |
| AlzeCure Pharma AB | 0.00 | -39.20m | 218.34m | 11.00 | -- | 4.31 | -- | -- | -0.4047 | -0.4047 | 0.00 | 0.4409 | 0.00 | -- | -- | 0.00 | -71.83 | -73.70 | -88.08 | -83.65 | -- | -- | -- | -- | -- | -- | 0.053 | -- | -- | -- | 5.20 | -- | -38.94 | -- |
| Promimic AB | 45.57m | -12.13m | 223.87m | 18.00 | -- | 3.67 | -- | 4.91 | -0.6388 | -0.6388 | 2.40 | 3.23 | 0.603 | -3.56 | 3.62 | 2,398,421.00 | -16.05 | -20.50 | -18.57 | -24.44 | 105.07 | 104.49 | -26.62 | -59.75 | 3.52 | -- | 0.00 | -- | 18.63 | 50.25 | -36.09 | -- | -- | -- |
| Sprint Bioscience AB | 49.53m | -25.65m | 228.97m | 29.00 | -- | 37.76 | -- | 4.62 | -0.2986 | -0.2986 | 0.5832 | 0.0575 | 1.47 | -- | 6.02 | 1,303,316.00 | -76.04 | -60.40 | -262.43 | -100.72 | 61.94 | 57.87 | -51.79 | -87.25 | -- | -36.01 | 0.00 | -- | 30.02 | 14.37 | -4,072.83 | -- | 69.39 | -- |
| Circio Holding ASA | 0.00 | -8.64m | 236.44m | 9.00 | 9.64 | -- | -- | -- | 0.1348 | 0.1348 | 0.00 | -0.0836 | 0.00 | -- | -- | 0.00 | -93.87 | -47.84 | -- | -58.78 | -- | -- | -- | -6,460.26 | -- | -- | -- | -- | -100.00 | -- | 150.93 | -- | 7.12 | -- |
| Xintela AB | 2.96m | -42.28m | 240.29m | 13.00 | -- | -- | -- | 81.26 | -0.0665 | -0.0665 | 0.0046 | -0.0396 | 0.3486 | -- | 6.47 | 227,461.50 | -498.42 | -194.17 | -- | -651.77 | 100.00 | -- | -1,429.86 | -6,272.93 | -- | -16.40 | -- | -- | 5,303.85 | 156.45 | 27.54 | -- | -- | -- |
| Bio-Works Technologies AB | 41.41m | -29.78m | 277.98m | 29.00 | -- | 7.57 | -- | 6.71 | -0.50 | -0.50 | 0.5878 | 0.3738 | 0.6931 | 0.9866 | 6.45 | 1,380,200.00 | -49.84 | -50.49 | -67.92 | -61.39 | 72.68 | 70.42 | -71.91 | -140.95 | 1.65 | -- | 0.00 | -- | -41.99 | 35.51 | 34.25 | -- | -48.46 | -- |
| Intervacc AB | 21.09m | -63.31m | 295.83m | 15.00 | -- | 0.9529 | -- | 14.03 | -0.3776 | -0.3776 | 0.09 | 0.911 | 0.079 | 0.8382 | 3.54 | 1,406,067.00 | -23.70 | -20.93 | -25.78 | -22.44 | 29.03 | -7.76 | -300.17 | -753.03 | 9.53 | -- | 0.0003 | -- | 47.06 | -0.5868 | 26.58 | -- | -52.41 | -- |
| Mendus AB (publ) | 0.00 | -113.26m | 301.66m | 27.00 | -- | 0.5045 | -- | -- | -2.17 | -2.17 | 0.00 | 9.55 | 0.00 | -- | -- | 0.00 | -17.10 | -17.73 | -17.89 | -18.72 | -- | -- | -- | -34,307.19 | -- | -- | 0.0312 | -- | -- | -- | 11.79 | -- | -7.93 | -- |
| Zelluna ASA | 0.00 | -132.17m | 384.06m | 26.00 | -- | 4.76 | -- | -- | -7.10 | -7.10 | 0.00 | 3.27 | 0.00 | -- | -- | -- | -128.29 | -44.36 | -165.31 | -49.63 | -- | -- | -- | -- | -- | -- | 0.008 | -- | -- | -- | 30.02 | -- | -41.59 | -- |
| Ascelia Pharma AB | 0.00 | -76.25m | 386.32m | 11.00 | -- | 3.92 | -- | -- | -0.693 | -0.693 | 0.00 | 0.7777 | 0.00 | -- | -- | -- | -60.31 | -54.24 | -85.44 | -64.44 | -- | -- | -- | -- | -- | -31.70 | 0.0097 | -- | -- | -- | 4.72 | -- | -32.17 | -- |
Data as of Feb 13 2026. Currency figures normalised to Intervacc AB's reporting currency: Swedish Krona SEK
4.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Coeli Asset Management ABas of 30 Jun 2025 | 6.49m | 1.90% |
| Fj�rde AP-fondenas of 31 Dec 2024 | 4.09m | 1.20% |
| Aktie-Ansvar ABas of 31 Dec 2024 | 1.22m | 0.36% |
| Nordea Investment Management ABas of 31 Dec 2024 | 1.04m | 0.31% |
| Aktia Bank Plc (Investment Management)as of 31 Dec 2024 | 836.75k | 0.25% |
| Alpcot Capital Management Ltd.as of 30 Jan 2026 | 472.50k | 0.14% |
| Cicero Fonder ABas of 31 Mar 2023 | 13.42k | 0.00% |
More ▼
Data from 30 Jun 2025 - 13 Feb 2026Source: FactSet Research Systems Inc.
